BACKGROUND: Benign familial neonatal seizures are most often caused by mutations in the voltage-gated potassium channel subunit gene KCNQ2. More than 60 mutations have been described in BFNS families, approximately half of which lead to protein truncation. The hypothesis of this study was that deletion or duplication of >or=1 exons of KCNQ2 could cause BFNS in cases without coding or splicing mutations. METHODS: Multiplex ligation-dependent probe amplification (MLPA) was used to test a group of 21 unrelated patients with clinical features consistent with either BFNS, benign familial neonatal-infantile seizures or sporadic neonatal seizures, for exonic deletions and duplications. RESULTS: Three deletions and one duplication mutation were identified in four familial cases and cascade testing of their available family members showed that the mutations segregated with the phenotype in each family. The junction fragment for one of the deletions was amplified by PCR and sequenced to characterise the breakpoint and verify that a deletion had occurred. CONCLUSIONS: Submicroscopic deletions or duplications of KCNQ2 are seen in a significant proportion of BFNS families: four of nine (44%) cases previously testing negative for coding or splice site mutation by sequencing KCNQ2 and KCNQ3. MLPA is an efficient second-tier testing strategy for KCNQ2 to identify pathogenic intragenic mutations not detectable by conventional DNA sequencing methods.
BACKGROUND:Benign familial neonatal seizures are most often caused by mutations in the voltage-gated potassium channel subunit gene KCNQ2. More than 60 mutations have been described in BFNS families, approximately half of which lead to protein truncation. The hypothesis of this study was that deletion or duplication of >or=1 exons of KCNQ2 could cause BFNS in cases without coding or splicing mutations. METHODS: Multiplex ligation-dependent probe amplification (MLPA) was used to test a group of 21 unrelated patients with clinical features consistent with either BFNS, benign familial neonatal-infantile seizures or sporadic neonatal seizures, for exonic deletions and duplications. RESULTS: Three deletions and one duplication mutation were identified in four familial cases and cascade testing of their available family members showed that the mutations segregated with the phenotype in each family. The junction fragment for one of the deletions was amplified by PCR and sequenced to characterise the breakpoint and verify that a deletion had occurred. CONCLUSIONS: Submicroscopic deletions or duplications of KCNQ2 are seen in a significant proportion of BFNS families: four of nine (44%) cases previously testing negative for coding or splice site mutation by sequencing KCNQ2 and KCNQ3. MLPA is an efficient second-tier testing strategy for KCNQ2 to identify pathogenic intragenic mutations not detectable by conventional DNA sequencing methods.
Authors: Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals Journal: Nucleic Acids Res Date: 2002-06-15 Impact factor: 16.971
Authors: M C Richards; S E Heron; H E Spendlove; I E Scheffer; B Grinton; S F Berkovic; J C Mulley; A Davy Journal: J Med Genet Date: 2004-03 Impact factor: 6.318
Authors: Eric Herlenius; Sarah E Heron; Bronwyn E Grinton; Deborah Keay; Ingrid E Scheffer; John C Mulley; Samuel F Berkovic Journal: Epilepsia Date: 2007-03-26 Impact factor: 5.864
Authors: C Biervert; B C Schroeder; C Kubisch; S F Berkovic; P Propping; T J Jentsch; O K Steinlein Journal: Science Date: 1998-01-16 Impact factor: 47.728
Authors: N A Singh; C Charlier; D Stauffer; B R DuPont; R J Leach; R Melis; G M Ronen; I Bjerre; T Quattlebaum; J V Murphy; M L McHarg; D Gagnon; T O Rosales; A Peiffer; V E Anderson; M Leppert Journal: Nat Genet Date: 1998-01 Impact factor: 38.330
Authors: Sarah E Heron; Kathryn M Crossland; Eva Andermann; Hilary A Phillips; Allison J Hall; Andrew Bleasel; Michael Shevell; Suha Mercho; Marie-Helene Seni; Marie-Christine Guiot; John C Mulley; Samuel F Berkovic; Ingrid E Scheffer Journal: Lancet Date: 2002-09-14 Impact factor: 79.321
Authors: Nanda A Singh; Peter Westenskow; Carole Charlier; Chris Pappas; Jonathan Leslie; Jessica Dillon; V Elving Anderson; Michael C Sanguinetti; Mark F Leppert Journal: Brain Date: 2003-10-08 Impact factor: 13.501
Authors: Samuel F Berkovic; Sarah E Heron; Lucio Giordano; Carla Marini; Renzo Guerrini; Robert E Kaplan; Antonio Gambardella; Ortrud K Steinlein; Bronwyn E Grinton; Joanne T Dean; Laura Bordo; Bree L Hodgson; Toshiyuki Yamamoto; John C Mulley; Federico Zara; Ingrid E Scheffer Journal: Ann Neurol Date: 2004-04 Impact factor: 10.422
Authors: Heather Olson; Yiping Shen; Jennifer Avallone; Beth R Sheidley; Rebecca Pinsky; Ann M Bergin; Gerard T Berry; Frank H Duffy; Yaman Eksioglu; David J Harris; Fuki M Hisama; Eugenia Ho; Mira Irons; Christina M Jacobsen; Philip James; Sanjeev Kothare; Omar Khwaja; Jonathan Lipton; Tobias Loddenkemper; Jennifer Markowitz; Kiran Maski; J Thomas Megerian; Edward Neilan; Peter C Raffalli; Michael Robbins; Amy Roberts; Eugene Roe; Caitlin Rollins; Mustafa Sahin; Dean Sarco; Alison Schonwald; Sharon E Smith; Janet Soul; Joan M Stoler; Masanori Takeoka; Wen-Han Tan; Alcy R Torres; Peter Tsai; David K Urion; Laura Weissman; Robert Wolff; Bai-Lin Wu; David T Miller; Annapurna Poduri Journal: Ann Neurol Date: 2014-06-13 Impact factor: 10.422
Authors: Ryan N Traylor; Damien L Bruno; Trent Burgess; Robert Wildin; Anne Spencer; Devika Ganesamoorthy; David J Amor; Matthew Hunter; Michael Caplan; Jill A Rosenfeld; Aaron Theisen; Beth S Torchia; Lisa G Shaffer; Blake C Ballif; Howard R Slater Journal: PLoS One Date: 2010-08-27 Impact factor: 3.240
Authors: Susan E Tomlinson; Hugh Bostock; Bronwyn Grinton; Michael G Hanna; Dimitri M Kullmann; Matthew C Kiernan; Ingrid E Scheffer; Samuel F Berkovic; David Burke Journal: Brain Date: 2012-10 Impact factor: 13.501